ID: hyp-SDA-2026-04-09-gap-debate-20260409-2
Hypothesis
pH-Activated Membrane Fusion Nanobodies
Nanobodies engineered with pH-sensitive membrane fusion domains could selectively penetrate vesicles in acidic microenvironments around tau aggregates while remaining inactive in normal physiological pH environments.
molecular biology
EvidencePending (0%)📖 5 cit🗣 1 debates✓ 5 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
Nanobodies engineered with pH-sensitive membrane fusion domains could selectively penetrate vesicles in acidic microenvironments around tau aggregates while remaining inactive in normal physiological pH environments.
🧬 Mechanism
🔗 Mechanism from KG for MAPT
Auto-built from this analysis's top knowledge-graph edges.
graph TD
phosphatidylserine_exposu["phosphatidylserine exposure"] -->|associated with| APOPTOSIS["APOPTOSIS"]
pH_sensitive_membrane_fus["pH-sensitive_membrane_fusion_domain"] -->|activates| acidic_microenvironment["acidic_microenvironment"]
phosphatidylserine_bindin["phosphatidylserine-binding_domain"] -->|binds| phosphatidylserine["phosphatidylserine"]
curvature_sensitive_cell_["curvature-sensitive_cell_penetrating_peptide"] -->|penetrates| curved_membranes["curved_membranes"]
ATP_depleted_environment["ATP-depleted_environment"] -->|enables| membrane_penetration["membrane_penetration"]
tau_protein["tau_protein"] -->|interacts with| phosphatidylserine_1["phosphatidylserine"]
tau_protein_2["tau_protein"] -->|induces| membrane_curvature["membrane_curvature"]
tau_aggregation["tau_aggregation"] -->|causes| pH_acidification["pH_acidification"]
tau_aggregation_3["tau_aggregation"] -->|disrupts| cholesterol_depletion["cholesterol_depletion"]
tau_conformational_change["tau_conformational_change"] -->|triggers| membrane_disruption["membrane_disruption"]
tau_aggregation_4["tau_aggregation"] -->|causes| ATP_depletion["ATP_depletion"]
tau_aggregation_5["tau_aggregation"] -->|disrupts| membrane_asymmetry["membrane_asymmetry"]
style phosphatidylserine_exposu fill:#4fc3f7,stroke:#333,color:#000
style APOPTOSIS fill:#ce93d8,stroke:#333,color:#000
style pH_sensitive_membrane_fus fill:#4fc3f7,stroke:#333,color:#000
style acidic_microenvironment fill:#4fc3f7,stroke:#333,color:#000
style phosphatidylserine_bindin fill:#4fc3f7,stroke:#333,color:#000
style phosphatidylserine fill:#4fc3f7,stroke:#333,color:#000
style curvature_sensitive_cell_ fill:#4fc3f7,stroke:#333,color:#000
style curved_membranes fill:#4fc3f7,stroke:#333,color:#000
style ATP_depleted_environment fill:#4fc3f7,stroke:#333,color:#000
style membrane_penetration fill:#4fc3f7,stroke:#333,color:#000
style tau_protein fill:#4fc3f7,stroke:#333,color:#000
style phosphatidylserine_1 fill:#4fc3f7,stroke:#333,color:#000
style tau_protein_2 fill:#4fc3f7,stroke:#333,color:#000
style membrane_curvature fill:#4fc3f7,stroke:#333,color:#000
style tau_aggregation fill:#4fc3f7,stroke:#333,color:#000
style pH_acidification fill:#4fc3f7,stroke:#333,color:#000
style tau_aggregation_3 fill:#4fc3f7,stroke:#333,color:#000
style cholesterol_depletion fill:#4fc3f7,stroke:#333,color:#000
style tau_conformational_change fill:#4fc3f7,stroke:#333,color:#000
style membrane_disruption fill:#4fc3f7,stroke:#333,color:#000
style tau_aggregation_4 fill:#4fc3f7,stroke:#333,color:#000
style ATP_depletion fill:#4fc3f7,stroke:#333,color:#000
style tau_aggregation_5 fill:#4fc3f7,stroke:#333,color:#000
style membrane_asymmetry fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
⚖️ Evidence Matrix5 supports3 contradicts
Supports
MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
Supports
Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Supports
Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules.
Supports
ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids.
Supports
The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes.
Contradicts
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.
Contradicts
Synergy between amyloid-β and tau in Alzheimer's disease.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — MAPT
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for MAPT.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0535
Events (7d)
0
Price History
▲6.0%💾 Resource Usage
LLM Tokens
12,936
$0.0776
Total Cost
$0.0776
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF we engineer nanobodies targeting MAPT with pH-sensitive membrane fusion domains THEN we will observe selective vesicular penetration at pH 6.0 versus no significant penetration at pH 7.4 within 48 | Mean fluorescence intensity of labeled nanobody inside vesicles will be ≥3-fold higher in pH 6.0 condition compared to pH 7.4 condition, as quantified by high-c | — no observation — | pending | 0.65 |
| IF pH-activated membrane fusion nanobodies selectively penetrate acidic tau aggregate vesicles THEN we will observe ≥30% reduction in Thioflavin T-positive tau aggregates after 72 hours of nanobody tr | Stereological count of Thioflavin T-positive tau inclusions in hippocampus will decrease by ≥30% in nanobody-treated 3xTG mice compared to vehicle-treated contr | — no observation — | pending | 0.55 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF we engineer nanobodies targeting MAPT with pH-sensitive membrane fusion domains THEN we will observe selective vesicular penetration at pH 6.0 versus no significant penetration at pH 7.4 within 48 hours of treatment in neuronal cell models.
Predicted outcome: Mean fluorescence intensity of labeled nanobody inside vesicles will be ≥3-fold higher in pH 6.0 condition compared to pH 7.4 condition, as quantified
Falsification: If nanobody vesicular uptake at pH 7.4 is >50% of uptake at pH 6.0, the pH-gating mechanism is insufficiently selective and the hypothesis is falsified.
pendingconf 55%
IF pH-activated membrane fusion nanobodies selectively penetrate acidic tau aggregate vesicles THEN we will observe ≥30% reduction in Thioflavin T-positive tau aggregates after 72 hours of nanobody treatment in a tauopathy mouse model.
Predicted outcome: Stereological count of Thioflavin T-positive tau inclusions in hippocampus will decrease by ≥30% in nanobody-treated 3xTG mice compared to vehicle-tre
Falsification: If Thioflavin T-positive inclusion counts show no significant difference (p>0.05) between nanobody and vehicle groups after 72 hours, the therapeutic efficacy hypothesis is falsified.
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesis
| source | v1_phase_c_backfill |
| origin_type | debate_synthesis |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.